EIR AstraZeneca Pharmaceuticals, LP Jan 2002

Tammy Chavis FDA, Donald Lech FDA, Vlada Matusovsky FDA, Debra Pagano FDA$595.00 - Available Now

FDA investigators audited the AstraZeneca Pharmaceuticals, LP - Newark, DE, United States facility and issued inspectional observation (via FDA 483) on 14 Jan 2002.

Product details

  • Category:
  • Inspection end: 14 Jan 2002
  • Location: Newark, United States
  • FEI: 2517100
Add To Cart